The agonist function of Ang-2 is essential for the development of the lymphatic vasculature, whereas its antagonist capacity facilitates the inhibition of the Ang-1/Tie-2 signaling pathways in cases of inflammation and cancer [31,34,37]. This evidence concerns the gene TEK and cancer.